IRCT20170608034390N9尚未招募3 期
Evaluation of the efficacy of eicosapentaenoic acid in patients with chronic migraine headache; a randomized controlled trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years（—）
- 性别
- All
入选标准
- •Patients with chronic migraine based on the ICHD-3 criteria
- •Ages between 18 and 50
- •Provide written consent
排除标准
- •Contraindications to EPA such as allergies
- •Patients with a history of bleeding disorders
- •Patients with increased risk of bleeding
- •Pregnant patients
- •Lactating patients
- •Patients treated with antiplatelet or anticoagulant drugs
研究者
相似试验
招募中
3 期
Evaluating the efficacy of eicosapentanoic acid on modified Rankin scale and inflammatory biomarkers in patients with ischemic stroke.Cerebral infarctionIschemic stroke.IRCT20170608034390N15Shahid Beheshti University of Medical Sciences90
已完成
不适用
Evaluation of the effect of eicosapentaenoic acid on plaques in human carotid arteriesAtherosclerotic plaques in carotid arteries.JPRN-UMIN000004114Institute of Health Biosciences, the University of Tokushima Graduate School, Department of Cardiovascular Medicine10
未知
不适用
Research on the efficacy of eicosapentaenoic acid (EPA) on coronary plaque formation in patients undergoing percutaneous coronary intervention.Patients underdoing percutaneous coronary intervention complicated with dyslipidemia.JPRN-UMIN000002059Cardiovascular Medicine. The University of Tokushima Institute of Health Biosciences, Graduate School.40
已完成
不适用
Evaluation of the impact of eicosapentaenoic acid on postprandial hyperglycemia, hyperliopemia and endothelial dysfunction in mild diabetic and impaired glucose tolerance patients with coronary artery disease.untreated mild diabetic patients (HbA1c<7.0%) and impaired glucose tolearenceJPRN-UMIN000011265Hyogo Brain and Heart Center80
已完成
3 期
Eicosapentaenoic acid in the treatment of pediatric atopic dermatitisIRCT20170608034390N2Shahid Beheshti University of Medical Sciences40